Lord, Abbett & Co
RXST icon

Lord, Abbett & Co’s RxSight RXST Stock Holding History

Lord, Abbett & Co’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,049,822
Closed -$51.9M – 575
2024
Q3 		$51.9M Sell
1,049,822
-685,463
-40% -$35.1M 0.17% 171
2024
Q2 		$104M Sell
1,735,285
-37,105
-2% -$2.12M 0.34% 79
2024
Q1 		$91.4M Sell
1,772,390
-204,610
-10% -$10M 0.3% 101
2023
Q4 		$79.7M Buy
1,977,000
+348,680
+21% +$10.2M 0.28% 107
2023
Q3 		$45.4M Buy
1,628,320
+197,099
+14% +$5.88M 0.17% 176
2023
Q2 		$41.2M Buy
1,431,221
+1,092,431
+322% +$24.3M 0.14% 205
2023
Q1 		$5.65M Buy
+338,790
New +$4.78M 0.02% 465

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Lord, Abbett & Co's RXST Position: Q4 2024 in Review

Lord, Abbett & Co sold out of RxSight (RXST) in Q4 2024, closing a stake of 1,049,822 shares — an estimated $51.9M sold.

Lord, Abbett & Co first reported a position in RXST in Q1 2023 and held it in 7 quarters. The position peaked at $104M in Q2 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

  • Lord, Abbett & Co reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
  • Lord, Abbett & Co sold 1,049,822 RxSight shares in Q4 2024, an estimated $51.9M.
  • Lord, Abbett & Co first reported a position in RxSight in Q1 2023 and held it in 7 quarters.
  • Lord, Abbett & Co's RxSight position peaked at $104M in Q2 2024.
  • 212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Lord, Abbett & Co's 13F filing for Q4 2024, filed 14 Feb 2025.